<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="194433">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00560625</url>
  </required_header>
  <id_info>
    <org_study_id>0030-07EMC</org_study_id>
    <nct_id>NCT00560625</nct_id>
  </id_info>
  <brief_title>Does Inhaled Busedonide or Fluticasone Impair Adrenal Function?</brief_title>
  <official_title>Low Dose(1mcg) ACTH Stimulation Test for Assessment of the Hypothalamus-pituitary-adrenal Axis in Patients Treated With Inhaled Busedonide or Fluticasone.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inhaled corticosteroids are largely used in patients with asthma or chronic obstructive lung
      diseases. The purpose of this study is to determine if the use of inhaled corticosteroids is
      associated with suppression of endogenous cortisol production, as seen in patients treated
      with pharmacologic doses of oral or parenteral steroids.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The normalcy of the hypothalmic-pituitary-adrenal (HPA) axis of enrolled subjects will be
      assessed by low dose (1mcg) corticotropin (ACTH)stimulation test. Serum cortisol levels will
      be measured before , 30 minutes and 60 minutes after 1 mcg ACTH intravenous injection.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    recruiting subjects did not start.
  </why_stopped>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>stimulated serum cortisol levels</measure>
    <time_frame>within 30 days of treatment</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Adrenal Insufficiency</condition>
  <eligibility>
    <study_pop>
      <textblock>
        hospital-based respiratory diseases clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients receiving inhaled busedonide or fluticasone at daily dose of 200-800 mcg '
             for at least 4 weeks

        Exclusion Criteria:

          -  patients receiving any corticosteroid therapy, except inhaled busedonide or
             fluticasone.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avraham Ishay, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Endocrine Institute , Haemek Medical Center, Afula. 18101 Israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Endocrine Institute, Haemek medical Center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 7, 2016</lastchanged_date>
  <firstreceived_date>November 18, 2007</firstreceived_date>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Adrenal Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fluticasone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
